Did not become law. It stopped in the Senate's Health & Human Services Committee on June 4, 2024. The 2023–2024 session has ended.
2023–2024 Regular Session
Senate Bill 1166
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for misbranding.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
6 co-sponsors
Wayne D. Fontana, John I. Kane, Vincent J. Hughes, Carolyn T. Comitta, Jay Costa, James R. Brewster
Its course
May 16 to June 4, 2024, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action2 actions on 2 days
In the SenateMay 16 to Jun 4 · stopped19 days
Health & Human ServicesMay 16 to Jun 4 · stopped19 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate May 16
- May 16Sent to HEALTH AND HUMAN SERVICES
All 2 actions, as published
- May 16Referred to HEALTH AND HUMAN SERVICES, May 16, 2024 [Senate]Senate
- Jun 4(Remarks see Senate Journal Page 378, 384), June 4, 2024 [Senate]Senate